Article Versions Notes

Fokam J, Chenwi CA, Takou D, Santoro MM, Tala V, Teto G, Beloumou G, Semengue ENJ, Dambaya B, Djupsa S, et al. Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens. Viruses. 2023; 15(8):1683. https://doi.org/10.3390/v15081683

Fokam, Joseph, Collins Ambe Chenwi, Desire Takou, Maria Mercedes Santoro, Valere Tala, George Teto, Grace Beloumou, Ezechiel Ngoufack Jagni Semengue, Beatrice Dambaya, Sandrine Djupsa, and et al. 2023. "Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens" Viruses 15, no. 8: 1683. https://doi.org/10.3390/v15081683

Fokam, J., Chenwi, C. A., Takou, D., Santoro, M. M., Tala, V., Teto, G., Beloumou, G., Semengue, E. N. J., Dambaya, B., Djupsa, S., Kembou, E., Bouba, N. P., Ajeh, R., Cappelli, G., Mbanya, D., Colizzi, V., Ceccherini-Silberstein, F., Perno, C.-F., & Ndjolo, A. (2023). Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens. Viruses, 15(8), 1683. https://doi.org/10.3390/v15081683